Skip to Main content Skip to Navigation
Journal articles

Protein Quality Control Pathways at the Crossroad of Synucleinopathies

Abstract : The pathophysiology of Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and many others converge at alpha-synuclein ($\alpha$-Syn) aggregation. Although it is still not entirely clear what precise biophysical processes act as triggers, cumulative evidence points towards a crucial role for protein quality control (PQC) systems in modulating $\alpha$-Syn aggregation and toxicity. These encompass distinct cellular strategies that tightly balance protein production, stability, and degradation, ultimately regulating $\alpha$-Syn levels. Here, we review the main aspects of $\alpha$-Syn biology, focusing on the cellular PQC components that are at the heart of recognizing and disposing toxic, aggregate-prone $\alpha$-Syn assemblies: molecular chaperones and the ubiquitin-proteasome system and autophagy-lysosome pathway, respectively. A deeper understanding of these basic protein homeostasis mechanisms might contribute to the development of new therapeutic strategies envisioning the prevention and/or enhanced degradation of $\alpha$-Syn aggregates.
Complete list of metadata

Cited literature [14 references]  Display  Hide  Download
Contributor : Mehdi KABANI Connect in order to contact the contributor
Submitted on : Wednesday, January 29, 2020 - 9:08:55 AM
Last modification on : Sunday, June 26, 2022 - 2:46:29 AM
Long-term archiving on: : Thursday, April 30, 2020 - 12:56:29 PM


Publication funded by an institution



Eduardo P. de Mattos, Anne Wentink, Carmen Nussbaum-Krammer, Christian Hansen, Steven Bergink, et al.. Protein Quality Control Pathways at the Crossroad of Synucleinopathies. Journal of Parkinson's disease, Amsterdam : b : IOS Press, In press, 14 pp. ⟨10.3233/JPD-191790⟩. ⟨cea-02458907⟩



Record views


Files downloads